Ebin, Mark .
HRN: 20-29-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
CEFTRIAXONE 1G (VIAL)
03/11/2026
03/17/2026
IV
2g
Q24
Typhoid
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: